Kathleen Hoke, JD
Professor Kathleen Hoke is director of the Network for Public Health Law, Eastern Region, and the Legal Resource Center for Public Health Policy at the University of Maryland Francis King Carey School of Law. She teaches the Public Health Law Clinic through which she engages law students in the work of the Network for Public Health Law and the Legal Resource Center for Public Health Policy. She also teaches Public Health and the Law, introducing students to the legal framework within which the public health system operates.The Network for Public Health Law was launched in September 2010 with the goal of providing technical legal assistance to national, state, and local public health professionals, their attorneys, legislators, and advocates working to develop sound public policy to improve public health. The Network for Public Health Law also develops 50-state law surveys, factsheets, issue briefs, webinars, and other useful tools on emerging and persistent public health issues. Under Professor Hoke’s direction, the Network for Public Health Law’s Eastern Region deliverables have focused on environmental health, food safety, and injury prevention. Professor Hoke has conducted research and prepared materials specifically related to hydrofracturing, medical marijuana laws, and health agency access to school health records.Through the Legal Resource Center for Public Health Policy, Professor Hoke provides technical legal assistance to Maryland state and local health officials, legislators, and organizations working in tobacco control. Recent work has focused on the regulation of electronic smoking devices (vapes), prohibition on the sale of flavored tobacco products, raising the age of access to tobacco to 21, and the development of sound policies to create smoke-free multiunit housing.Professor Hoke joined the faculty in 2002 after serving for eight years with the Office of the Attorney General of Maryland. During her tenure as an assistant attorney general, she served in the Civil Litigation Division and the Opinions and Advice Division. As a special assistant attorney general, she worked on a variety of public health initiatives, including tobacco regulation and gun control, and represented the office in multistate cases through the National Association of Attorneys General.Professor Hoke graduated from the University of Maryland School of Law in 1992, having served on the executive board of the Maryland Law Review and as a member of the National Moot Court Team.
More from Youtube
- 4:51Using AI to Prevent Medical Errors | Breakthroughs Can’t WaitWhat if your dentist had a second set of eyes — powered by AI — to help spot cancer earlier and improve patient outcomes?That’s the driving question behind the work of Ahmed Sultan, BDS, PhD, a pioneer in the use of artificial intelligence (AI) in oral health care. Sultan directs the Division of Artificial Intelligence Research at the University of Maryland School of Dentistry, the first such division at a dental school in the United States. His work is advancing a new era of diagnostics, where AI tools assist clinicians in detecting disease earlier, improving outcomes, and closing care gaps.“We’re seeing more administrative burden and clinician fatigue, which increases the risk of missing things,” Sultan explained. “AI can triage cases and flag abnormalities early, helping dentists and pathologists prioritize serious conditions before they’re overlooked.”๐ Learn more: https://www.umaryland.edu/breakthroughs#NIHResearch #HealthcareInnovation #DiagnosticAccuracy #HospitalSafety #HealthTech #BreakthroughsCantWaitUMB #UMD #UMB #universityofmaryland #Dentistry #radiology #Science #artificialintelligence #aiinhealthcare
- 0:44Using AI to Catch Oral Cancer Early | Breakthroughs Can’t WaitWhat if artificial intelligence could help spot oral cancer earlier — before symptoms even appear?At the University of Maryland School of Dentistry, Ahmed Sultan is leading NIH-funded research to develop AI tools that detect early-stage oral cancer, especially in communities with limited access to care. This work combines innovation and equity to save lives through faster, more accurate diagnosis.๐ Learn more: https://vist.ly/3n5gjp9#OralCancer #EarlyDetection #AIHealthTech #AhmedSultan #NIHResearch #HealthcareEquity #MedicalInnovation #BreakthroughsCantWait #CancerScreening #Science #Dentistry
- 0:40A Diabetes Drug That Regrows Bone? | Breakthroughs Can’t WaitMetformin was designed to treat type 2 diabetes.Now, Abraham Schneider, DDS, PhD, at @UMSOD is uncovering how this affordable medication could support craniofacial bone regeneration — helping patients heal after oral trauma, surgery, or disease.Supported by the National Institutes of Health, his work represents a potential breakthrough in non-invasive bone repair and oral health innovation.https://umaryland.edu/breakthroughs#BreakthroughsCantWaitUMB #NIHResearch #MetforminScience #BoneHealing #DentalInnovation #MedicalResearch #Science #Dentistry #DentalSurgery
- 0:51Rethinking Bone Healing | Breakthroughs Can’t WaitCould an affordable diabetes drug change how we rebuild bone after trauma?Abraham Schneider, DDS, PhD, at the University of Maryland School of Dentistry is investigating how metformin supports bone regeneration — not just in theory, but as a real, low-cost solution for treating injuries to the face and jaw.Supported by the National Institutes of Health, this research opens the door to non-invasive, drug-based alternatives to traditional bone grafting techniques — a promising breakthrough for oral surgeons and trauma recovery specialists.๐ Learn more: https://vist.ly/3n4yu4g #BreakthroughsCantWait #BoneHealing #NIHResearch #DentalInnovation #MetforminScience #OralHealthCare #Research #Science #MedicalBreakthroughs
- 4:55Can a Diabetes Medication Help Regrow Jawbone? | Breakthroughs Can’t WaitCould a pill designed for blood sugar control help rebuild the human jaw?That’s one of the questions driving Abraham Schneider, DDS, PhD, associate professor and chair of the Department of Oncology and Diagnostic Sciences at the University of Maryland School of Dentistry. With support from the National Institutes of Health, Schneider is studying how metformin, a widely used and affordable drug for type 2 diabetes, might also help regenerate craniofacial bone — offering a new, cost-effective strategy to treat damage caused by trauma or disease.“We are trying to regenerate a craniofacial bone that is affected by several conditions, including periodontal disease and trauma,” Schneider said. “So, we are trying to look for new ways of regenerating bone.”#OralCancer #DentalResearch #BreakthroughsCantWait #NIHResearch #HeadNeckCancer #CraniofacialBiology #CancerTreatment #UniversityOfMaryland #MedicalBreakthroughs
- 0:36Can a Diabetes Med Help Regrow Bone? | Breakthroughs Can’t WaitWhat if we could regenerate bone using a medication already on the market?At the University of Maryland, Baltimore, researchers are exploring how metformin — a drug commonly used to treat diabetes — could be repurposed to stimulate bone growth and healing.This is just one of many NIH-funded breakthroughs at UMB with the power to transform medicine and save lives.๐งช Breakthroughs Can’t Wait: UMB research drives innovation, improves lives, and tackles global challenges. But we can’t do it without continued support.๐ Learn more and support research that saves lives: https://www.umaryland.edu/breakthroughs#BreakthroughsCantWait #BoneRegeneration #MetforminResearch #DiabetesDrugInnovation #MedicalBreakthroughs #UMBResearch #NIHfunding #TissueEngineering